星宏傳媒(01616.HK):天人科技受讓6000萬港元公司債券
格隆匯10月30日丨星宏傳媒(01616.HK)公佈,公司收到原債券持有人Dragon Capital Entertainment Fund One LP就轉讓本金總額為6000萬港元的債券予天人科技有限公司的轉讓通知,該債券按每股換股股份0.74港元的經調整換股價可轉換為8108萬股換股股份。
緊隨天人科技債券轉讓完成後,天人科技將成為本金總額為6000萬港元的債券的註冊持有人,而原債券持有人將仍為本金總額為1.2億港元的債券的註冊持有人。
據悉,天人科技為根據香港法律註冊成立及存續的有限公司;及天人科技及其最終實益擁有人均為獨立於公司、原債券持有人的第三方。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.